Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 298 followers
Latest posts
Last updated 3 days ago
Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation: 27/03/2014, Revision: 18, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Adempas, riociguat, Date of authorisation...
Human medicines European public assessment report (EPAR): Piasky, crovalimab, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Piasky, crovalimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Yttriga, yttrium [90Y] chloride, Date of authorisation: 19/01/2006, Revision: 11, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Yttriga, yttrium [90Y] chloride, Date...
Human medicines European public assessment report (EPAR): Yuvanci, macitentan,tadalafil, Date of authorisation: 27/09/2024, Revision: 2, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Yuvanci, macitentan,tadalafil, Date of authorisation...
Human medicines European public assessment report (EPAR): Sephience, sepiapterin, Date of authorisation: 19/06/2025, Revision: 3, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Sephience, sepiapterin, Date of authorisation...
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 2, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation...
Summary of opinion: Braftovi, 21/05/2026 Positive
3 days ago
Summary of opinion: Braftovi, 21/05/2026 Positive
Summary of opinion: Iclusig, 21/05/2026 Positive
3 days ago
Summary of opinion: Iclusig, 21/05/2026 Positive
Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Status: Opinion
3 days ago
Human medicines European public assessment report (EPAR): Colchicine Agepha Pharma, colchicine, Status...
Human medicines European public assessment report (EPAR): Deqtynet, copper (64Cu) oxodotreotide, Status: Opinion
3 days ago
Human medicines European public assessment report (EPAR): Deqtynet, copper (64Cu) oxodotreotide, Status...
Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of authorisation: 22/07/2014, Revision: 14, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of...